Close Menu

Johns Hopkins

The team found that telomere fusions in pancreatic cells can act as potential predictive biomarkers for invasive cancer and high grade dysplasia in patients.

The company has been working for several years under NIH grants totaling more than $7 million and is now preparing for its first formal product launch.

The wide-ranging discussion with witnesses from Stanford, Johns Hopkins, and Editas Medicine touched on recent advances in research and questions of safety.

In Nature this week: new class of base editors, additional breast cancer risk loci, and more.

The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.

Johns Hopkins' Evgeny Izumchenko is also developing a blood test for the non-invasive detection and followup of early tumors.

A Johns Hopkins team reported its finding in JAMA Cardiology, backed by SNP array data from 21,870 participants culled from several large cardiovascular studies.

A new set of papers reveals a range of gene expression influencers, identified using thousands of samples collected for the Genotype-Tissue Expression project.

In PNAS this week: links between the gut microbiome and multiple sclerosis, and more.

Rejected Evidence

Hopkins' Joshua Sharfstein writes at JAMA Forum about how the Trump administration has been dealing with scientific evidence.

Pages

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.